Yotov W V, Moreau A, St-Arnaud R
Shriners Hospital, and Department of Surgery, McGill University, Montréal, Québec, Canada.
Mol Cell Biol. 1998 Mar;18(3):1303-11. doi: 10.1128/MCB.18.3.1303.
We report the characterization of clone 1.9.2, a gene expressed in mineralizing osteoblasts. Remarkably, clone 1.9.2 is the murine homolog of the alpha chain of the nascent polypeptide-associated complex (alpha-NAC). Based on sequence similarities between alpha-NAC/1.9.2 and transcriptional regulatory proteins and the fact that the heterodimerization partner of alpha-NAC was identified as the transcription factor BTF3b (B. Wiedmann, H. Sakai, T. A. Davis, and M. Wiedmann, Nature 370:434-440, 1994), we investigated a putative role for alpha-NAC/ 1.9.2 in transcriptional control. The alpha-NAC/1.9.2 protein potentiated by 10-fold the activity of the chimeric activator GAL4/VP-16 in vivo. The potentiation was shown to be mediated at the level of gene transcription, because alpha-NAC/1.9.2 increased GAL4/VP-16-mediated mRNA synthesis without affecting the half-life of the GAL4/VP-16 fusion protein. Moreover, the interaction of alpha-NAC/1.9.2 with a transcriptionally defective mutant of GAL4/VP-16 was severely compromised. Specific protein-protein interactions between alpha-NAC/1.9.2 and GAL4/VP-16 were demonstrated by gel retardation, affinity chromatography, and protein blotting assays, while interactions with TATA box-binding protein (TBP) were detected by immunoprecipitation, affinity chromatography, and protein blotting assays. Based on these interactions that define the coactivator class of proteins, we conclude that the alapha-NAC/1.9.2 gene product functions as a transcriptional coactivator.
我们报告了克隆1.9.2的特性,该基因在矿化成骨细胞中表达。值得注意的是,克隆1.9.2是新生多肽相关复合体(α-NAC)α链的小鼠同源物。基于α-NAC/1.9.2与转录调节蛋白之间的序列相似性,以及α-NAC的异源二聚化伙伴被鉴定为转录因子BTF3b这一事实(B. 维德曼、H. 酒井、T. A. 戴维斯和M. 维德曼,《自然》370:434 - 440,1994),我们研究了α-NAC/1.9.2在转录调控中的假定作用。α-NAC/1.9.2蛋白在体内使嵌合激活剂GAL4/VP-16的活性增强了10倍。这种增强作用被证明是在基因转录水平介导的,因为α-NAC/1.9.2增加了GAL4/VP-16介导的mRNA合成,而不影响GAL4/VP-16融合蛋白的半衰期。此外,α-NAC/1.9.2与GAL4/VP-16的转录缺陷突变体之间的相互作用严重受损。通过凝胶阻滞、亲和层析和蛋白质印迹分析证明了α-NAC/1.9.2与GAL4/VP-16之间存在特异性蛋白质-蛋白质相互作用,而通过免疫沉淀、亲和层析和蛋白质印迹分析检测到了与TATA盒结合蛋白(TBP)的相互作用。基于这些定义了共激活剂类蛋白质的相互作用,我们得出结论,α-NAC/1.9.2基因产物作为转录共激活剂发挥作用。